These effects, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the thought of focusing on ACKR3 as a novel way to modulate the opioid method, which could open new therapeutic avenues for opioid-similar Issues.At that time, Microsoft Advertising and marketing will m